Abstract: System and method to reduce risk of patient infections (HAI), using operating rooms (chambers) equipped with suitable automatic airborne sterilizing agent generators, sensors, mechanisms, automatic air control devices, and laminar flow devices. After suitable safety checks, the system isolates the interior air from external air, and activates an air phase anti-microbial agent generator, filling the room with an air-phase anti-microbial agent. After sterilization, the invention deactivates the generator then restores the connection to outside sterilized air. The chamber also comprises an intelligent platform comprising video cameras, and computer vision systems configured to identify humans and medical supplies, read optical tags, and correlate recognized objects with RFID tag data.

Abstract: System and method to reduce risk of exposure to pathogens using a system comprising transportable clinical chambers, often configured with the exterior dimensions of a shipping container. The transportable chamber can be partially or completely self-contained, and configured for rapid transport and setup. The chamber is typically equipped with suitable automatic airborne sterilizing agent generators, sensors, mechanisms, and automatic air control devices. After suitable safety checks, the system isolates the interior air from external air, and activates an air phase anti-microbial agent generator, filling at least a portion of the chamber with an air-phase anti-pathogen agent. After sterilization, the invention deactivates the generator and then restores the connection to outside sterilized air.

Abstract: Embodiments include adjuvant formulations containing an alkoxylated alkanol adjuvant having the following alkanol structure: where the total number of carbon atoms of R1 and R2 are from about 3 to about 36, R2 can be hydrogen or C1 to C18, and R2 may or may not be branched, and wherein the alkoxylate is one of ethylene oxide, propylene, or mixture thereof. Further embodiments included methods for making and using the alkoxylated alkanol adjuvant formulations.

Abstract: A gas turbine engine which includes a starter/generator mechanically coupled thereto and an electric oil pump motor for driving an oil pump is started in a manner which assures a continuous and uninterrupted supply of lubricating oil to the moving components of the engine. According to one method, first and second motor controllers initiate operation of the oil pump motor. Thereupon, the second motor controller is re-directed to initiate operation of the starter/generator and the gas turbine engine itself, after which, the second motor controller again joins the first motor controller to accelerate the oil pump motor up to idle speed. The oil pump motor may then be electrically coupled to the starter/generator for continued operation. In another mode of operation, a second motor controller may not be used at all. In that event, the alternating electric power supply for the vehicle powered by the gas turbine engine may be used as an interim source for controlling the speed of the oil pump motor.

Abstract: A plurality of accessories operatively associated with a gas turbine engine are driven by electric motors. A first motor controller initiates operation of a starter/generator mechanically coupled to the engine. After the engine has been started, the motor controller is used to accelerate other accessory motors at a predetermined rate after which they are each electrically coupled to the starter/generator for continued operation. Throughout this operation, the first motor controller serves as a back up for a second motor controller which is dedicated to the operation of a fuel pump motor. Other modes of operation can be achieved as well by reason of the flexibility provided by motor driven accessories.

Abstract: The present invention relates to a polyisocyanate adduct mixture which at a 100% solids concentration has an isocyanate content of about 4 to 19 weight percent and is liquid at room temperature. The adduct mixture is prepared from a biuret-containing polyisocyanate and a monohydroxy alcohol which contains 11 to 36 carbon atoms. The adduct mixture possesses good storage stability in common polyisocyanate solvents and good compatibility with apolar solvents. The present invention also relates to the use of the liquid polyisocyante adduct mixture in the process of curing alkyd or acrylic resins and to compositions containing the adduct mixture and alkyd or acrylic resins.

Abstract: The present invention relates to a modified polyisocyanate having improved compatibility with aliphatic hydrocarbon solvents comprising the reaction product of(a) an aliphatic biuret isocyanate having the formula ##STR1## and (b) about 0.05 to 0.5 mols per equivalent of isocyanate of an aliphatic monohydroxy alcohol having at least 8 carbon atoms.

Abstract: The present invention is directed to light stable polyisocyanate adduct mixtures with an average functionality greater than 2.0 and an isocyanate content of between about 4 and 19 percent by weight based on solids, which has good compatibility with apolar solvents and good storage stability in a solution of polyisocyanate solvents. The polyisocyanate adduct mixtures are based on the reaction product of a polyisocyanate, preferably a biuret-containing polyisocyanate, with a first monohydroxy compound containing a saturated hydrocarbon chain of at least 8 carbon atoms and a second monohydroxy compound containing at least one polarity inducing group. Alternatively, both the saturated hydrocarbon chain and the polarity inducing group may be present in the same monohydroxy compound.The present invention is additionally directed to the use of the polyisocyanate adduct mixtures in the process of curing alkyd or acrylic resins and to compositions containing the adduct mixture and alkyd or acrylic resins.

Abstract: A polymerizable material is formed by the reaction of: (A) acrylamide or methacrylamide; (B) from 1.5 to 2 moles, per mole of acrylamide or methacrylamide, of formaldehyde; and (C) an amount equivalent to the formaldehyde of a hydroxyl-group containing component comprising one or more hydroxyl or group-containing compounds containing from 1 to 4 primary or secondary hydroxyl groups per molecule, at least one of the hydroxyl groups-containing compounds being a monoacrylate or monomethacrylate of a diprimary, disecondary or primary-secondary diol, the said monoacrylate or monomethacrylate being used in an amount of from 0.1 to k mole, per mole of acrylamide or methacrylamide, when the average number of hydroxyl groups per molecule of the hydroxyl group-containing component is 1 and in an amount of from 0.